TipRanks
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
US Market
OKYO
OKYO Pharma Limited Sponsored ADR
RESEARCH TOOLSreports
Want to see OKYO full AI Analyst Report?

OKYO Pharma Limited Sponsored ADR (OKYO) Income Statement

121 Followers

OKYO Pharma Limited Sponsored ADR Income Statement

Last quarter (Q4 2026), OKYO Pharma Limited Sponsored ADR's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, OKYO Pharma Limited Sponsored ADR's net income was $-6.36M. See OKYO Pharma Limited Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Jun 25Jun 24Jun 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.69M$ -2.56K$ -7.51M$ -6.75M$ -13.00K
Operating Expenses
$ 1.81M$ 7.19M$ 8.24M$ 6.34M$ 6.22M
Depreciation and Amortization
$ 1.82K$ 2.56K$ 3.87K$ 3.80K$ 2.33K
EBITDA
$ -8.47M$ -7.08M$ -15.75M$ -13.08M$ -6.21M
Operating Income
$ -8.50M$ -7.19M$ -15.75M$ -13.09M$ -6.23M
Other Income/Expenses
$ -442.12K$ -781.20K$ -1.05M$ -196.41K$ 13.00K
Pretax Income
$ -8.94M$ -7.97M$ -16.80M$ -13.28M$ -6.22M
Net Income
$ -8.95M$ -4.71M$ -16.83M$ -13.27M$ -5.43M
Per Share Metrics
Basic EPS
$ -0.24$ -0.12$ >-0.01$ -0.60$ -0.36
Diluted EPS
$ -0.24$ -0.12$ >-0.01$ -0.60$ -0.36
Weighted Average Shares Outstanding
 37.36M 39.49M 29.34M 22.26M 15.06M
Weighted Average Shares Outstanding (Diluted)
 37.36M 39.49M 29.34M 22.26M 15.06M
Currency in USD

OKYO Pharma Limited Sponsored ADR Earnings and Revenue History